;PMID: 115774 ;source_file_1012.mrg ;Release 0.9 of PennBioIE ;Funded by NSF ITR EIA-0205448 ;0)section:[e:0..28] = [t:0..28] ;1)sentence:[e:34..100] = [t:34..100] ;2)section:[e:104..131] = [t:104..131] ;3)sentence:[e:135..288] = [t:135..288] ;4)sentence:[e:290..395] = [t:290..395] ;5)sentence:[e:396..546] = [t:396..546] ;6)sentence:[e:547..735] = [t:547..735] ;7)section:[e:739..782] = [t:739..782] ;section 0 Span:0..28 ;Horm Res. 1979;11(4):179-85. (SEC (FRAG (NNP:[0..4] Horm) (NNP:[5..8] Res) (.:[8..9] .) ('':[10..18] 1979;11-LRB-) (VBD:[18..20] 4-RRB-) (CD:[20..24] :179) (::[24..25] -) (CD:[25..27] 85) (.:[27..28] .))) ;sentence 1 Span:34..100 ;Subcellular distribution of aromatase in human placenta and ovary. ;[62..71]:substance:"aromatase" (SENT (NP-HLN (NP (JJ:[34..45] Subcellular) (NN:[46..58] distribution)) (PP (IN:[59..61] of) (NP (NN:[62..71] aromatase))) (PP-LOC (IN:[72..74] in) (NP (NP (ADJP-1 (JJ:[75..80] human)) (NN:[81..89] placenta)) (CC:[90..93] and) (NP (ADJP-1 (-NONE-:[93..93] *P*)) (NN:[94..99] ovary)))) (.:[99..100] .))) ;section 2 Span:104..131 ;Thompson EA Jr, Siiteri PK. (SEC (FRAG (NNP:[104..112] Thompson) (NNP:[113..115] EA) (NNP:[116..118] Jr) (,:[118..119] ,) (NNP:[120..127] Siiteri) (NNP:[128..131] PK.))) ;sentence 3 Span:135..288 ;The aromatization of androstenedione in human ovarian microsomes is inhibited ;by an antibody to porcine hepatic microsomal NADPH-cytochrome c reductase. ;[156..171]:substance:"androstenedione" ;[220..228]:substance:"antibody" ;[259..287]:substance:"NADPH-cytochrome c reductase" (SENT (S (NP-SBJ-1 (NP (DT:[135..138] The) (NN:[139..152] aromatization)) (PP (IN:[153..155] of) (NP (NN:[156..171] androstenedione))) (PP-LOC (IN:[172..174] in) (NP (JJ:[175..180] human) (JJ:[181..188] ovarian) (NNS:[189..199] microsomes)))) (VP (VBZ:[200..202] is) (VP (VBN:[203..212] inhibited) (NP-1 (-NONE-:[212..212] *)) (PP (IN:[213..215] by) (NP-LGS (NP (DT:[217..219] an) (NN:[220..228] antibody)) (PP (TO:[229..231] to) (NP (JJ:[232..239] porcine) (JJ:[240..247] hepatic) (JJ:[248..258] microsomal) (NML (NN:[259..264] NADPH) (HYPH:[264..265] -) (NN:[265..275] cytochrome) (NN:[276..277] c)) (NN:[278..287] reductase))))))) (.:[287..288] .))) ;sentence 4 Span:290..395 ;Likewise, the antibody inhibits aromatization in mitochondria isolated from ;human ovaries and placentae. ;[304..312]:substance:"antibody" (SENT (S (ADVP (RB:[290..298] Likewise)) (,:[298..299] ,) (NP-SBJ (DT:[300..303] the) (NN:[304..312] antibody)) (VP (VBZ:[313..321] inhibits) (NP (NN:[322..335] aromatization)) (PP-LOC (IN:[336..338] in) (NP (NP (NNS:[339..351] mitochondria)) (VP (VBN:[352..360] isolated) (NP (-NONE-:[360..360] *)) (PP (IN:[361..365] from) (NP (NP (ADJP-1 (JJ:[367..372] human)) (NNS:[373..380] ovaries)) (CC:[381..384] and) (NP (ADJP-1 (-NONE-:[384..384] *P*)) (NNS:[385..394] placentae)))))))) (.:[394..395] .))) ;sentence 5 Span:396..546 ;A given quantity of the antibody produces the same percent inhibition of ;aromatization in microsomes and mitochondria of both ovaries and placentae. ;[420..428]:substance:"antibody" (SENT (S (NP-SBJ (NP (DT:[396..397] A) (JJ:[398..403] given) (NN:[404..412] quantity)) (PP (IN:[413..415] of) (NP (DT:[416..419] the) (NN:[420..428] antibody)))) (VP (VBZ:[429..437] produces) (NP (NP (DT:[438..441] the) (JJ:[442..446] same) (NN:[448..455] percent) (NN:[456..466] inhibition)) (PP (IN:[467..469] of) (NP (NN:[470..483] aromatization)))) (PP-LOC (IN:[484..486] in) (NP (NP (NNS:[487..497] microsomes) (CC:[498..501] and) (NNS:[502..514] mitochondria)) (PP (IN:[515..517] of) (NP (CC:[518..522] both) (NNS:[524..531] ovaries) (CC:[532..535] and) (NNS:[536..545] placentae)))))) (.:[545..546] .))) ;sentence 6 Span:547..735 ;These data, in addition to the low specific activity observed for the ;mitochondrial aromatase, indicate that aromatization in mitochondria ;probably results from microsomal contamination. ;[632..641]:substance:"aromatase" (SENT (S (NP-SBJ (DT:[547..552] These) (NNS:[553..557] data)) (,:[557..558] ,) (PP (IN:[559..561] in) (NP (NP (NN:[562..570] addition)) (PP (TO:[571..573] to) (NP (NP (DT:[574..577] the) (JJ:[578..581] low) (JJ:[582..590] specific) (NN:[591..599] activity)) (VP (VBN:[601..609] observed) (NP (-NONE-:[609..609] *)) (PP (IN:[610..613] for) (NP (DT:[614..617] the) (JJ:[618..631] mitochondrial) (NN:[632..641] aromatase)))))))) (,:[641..642] ,) (VP (VBP:[643..651] indicate) (SBAR (IN:[652..656] that) (S (NP-SBJ (NP (NN:[657..670] aromatization)) (PP (IN:[671..673] in) (NP (NNS:[675..687] mitochondria)))) (ADVP (RB:[688..696] probably)) (VP (VBZ:[697..704] results) (PP (IN:[705..709] from) (NP (JJ:[710..720] microsomal) (NN:[721..734] contamination))))))) (.:[734..735] .))) ;section 7 Span:739..782 ;PMID: 115774 [PubMed - indexed for MEDLINE] (SEC (FRAG (NNP:[739..743] PMID) (::[743..744] :) (CD:[745..751] 115774) (NN:[752..753] -LSB-) (NNP:[753..759] PubMed) (::[760..761] -) (NN:[762..769] indexed) (IN:[770..773] for) (NNP:[774..782] MEDLINE-RSB-)))